Psychiatric-Mental Health Nurse Practitioner (PMHNP) BLITZ Certification Review and Clinical Update Continuing Education Course (Nov 12 - 13, 2026)

Psychiatric-Mental Health Nurse Practitioner (PMHNP) BLITZ Certification Review and Clinical Update Continuing Education Course is organized by Barkley & Associates, Inc. and will be held from Nov 12 - 13, 2026.

Description:
Psychiatric-Mental Health Nurse Practitioner (PMHNP)

Extensive Review of Psychiatric-Mental Health Conditions Across the Lifespan (DSM-5)

Certification Review and Clinical Update Continuing Education Course

Assessment of Acute and Chronic Illness

• Anatomy, physiology, and pathophysiology
• Crisis intervention, de-escalation techniques
• Diagnostic testing, differential diagnoses
• Plan of care
• Prioritization
• Psychiatric evaluations
• Referral/collaborative practice
• Screening methods

Diagnosis and Clinical Management for Adults

• Clinical guidelines
• Documentation
• Establishing plan of care
• Evaluating treatment and outcomes
• Health promotion
• Integrating and applying evidence-based practice
• Management of acute, chronic, and complex conditions
• Patient teaching
• Risk factor management
• Service consultation and/or referral
• Standards of care

Diagnosis and Clinical Management for Children

• Anxiety disorders of childhood and adolescence
• Conduct disorders
• Developmental aspects of the brain
• Ethological theories
• Gender dysphoria
• Genetic considerations
• Human sexuality
• Intellectual disabilities
• Pervasive disorders
• Theories of development

Health Promotion and Disease Prevention

• Diverse population considerations
• Epidemiology
• Growth and development considerations
• Patient and family teaching
• Primary, secondary, and tertiary prevention
• Risk analysis
• Screening recommendations
• Up-to-date statistics

Nurse Practitioner/Patient Relationship and Professional Role/Policy

• Access to care
• Advanced directives
• Billing and coding
• Collaboration
• Cultural competence and sensitivity
• Establishing rapport
• Family dynamics
• Informed consent
• Legal and ethical principles
• National mandates/federal guidelines
• Patient autonomy
• Professional therapeutic relationships
• Privacy and confidentiality
• Reimbursement
• Research methods
• Scope and standards of practice
• Social support
• Therapeutic communication

Psychiatric/Mental Health Issues and Disorders

• Childhood
• Disruptive, impulse control, conduct
• Feeding and eating
• Mood
• Neurocognitive
• Personality
• Schizophrenia spectrum, psychosis
• Serious mental illness
• Stress, anxiety, somatic
• Substance-related, addictive

Psychobiology and Psychopharmacology

• Adverse events
• Alternative therapies/herbal agents
• Anti-Parkinsonian drugs
• Antidepressants
• Antiepileptics
• Anxiolytics
• Drug monitoring recommendations
• Drug interactions
• Mood stabilizers
• Neuroregulation
• Psychoendocrinology
• Pharmacokinetics
• Stimulants